Search

Gyan Chandra

Examiner (ID: 3544, Phone: (571)272-2922 , Office: P/1646 )

Most Active Art Unit
1646
Art Unit(s)
1674, 1646
Total Applications
1422
Issued Applications
816
Pending Applications
139
Abandoned Applications
480

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6658381 [patent_doc_number] => 20030133972 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-17 [patent_title] => 'Targeted multivalent macromolecules' [patent_app_type] => new [patent_app_number] => 10/159596 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34686 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0133/20030133972.pdf [firstpage_image] =>[orig_patent_app_number] => 10159596 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/159596
Targeted multivalent macromolecules May 29, 2002 Abandoned
Array ( [id] => 6855722 [patent_doc_number] => 20030129223 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Targeted multivalent macromolecules' [patent_app_type] => new [patent_app_number] => 10/158777 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 34634 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20030129223.pdf [firstpage_image] =>[orig_patent_app_number] => 10158777 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/158777
Targeted multivalent macromolecules May 29, 2002 Abandoned
10/031490 Combined preparations comprising antitumor agents May 9, 2002 Abandoned
Array ( [id] => 6725047 [patent_doc_number] => 20030207359 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-06 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/141756 [patent_app_country] => US [patent_app_date] => 2002-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 551 [patent_figures_cnt] => 551 [patent_no_of_words] => 63542 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20030207359.pdf [firstpage_image] =>[orig_patent_app_number] => 10141756 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/141756
PRO4409 polypeptides May 7, 2002 Issued
Array ( [id] => 6696290 [patent_doc_number] => 20030108484 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-12 [patent_title] => 'Individualization of therapy with antineoplastic agents' [patent_app_type] => new [patent_app_number] => 10/135185 [patent_app_country] => US [patent_app_date] => 2002-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 42967 [patent_no_of_claims] => 83 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20030108484.pdf [firstpage_image] =>[orig_patent_app_number] => 10135185 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/135185
Individualization of therapy with antineoplastic agents Apr 28, 2002 Abandoned
Array ( [id] => 711553 [patent_doc_number] => 07057021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-06-06 [patent_title] => 'Genes encoding caspase recruitment domain polypeptides' [patent_app_type] => utility [patent_app_number] => 10/133780 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 24703 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/057/07057021.pdf [firstpage_image] =>[orig_patent_app_number] => 10133780 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/133780
Genes encoding caspase recruitment domain polypeptides Apr 25, 2002 Issued
Array ( [id] => 6739742 [patent_doc_number] => 20030157111 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => '76A11 polypeptide and uses thereof' [patent_app_type] => new [patent_app_number] => 10/128736 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 13621 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157111.pdf [firstpage_image] =>[orig_patent_app_number] => 10128736 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/128736
76A11 polypeptide and uses thereof Apr 22, 2002 Abandoned
Array ( [id] => 728644 [patent_doc_number] => 07041643 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Molecules of the PYRIN/NBS/LRR protein family and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/124498 [patent_app_country] => US [patent_app_date] => 2002-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 62338 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041643.pdf [firstpage_image] =>[orig_patent_app_number] => 10124498 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/124498
Molecules of the PYRIN/NBS/LRR protein family and uses thereof Apr 16, 2002 Issued
Array ( [id] => 7296072 [patent_doc_number] => 20040214248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Use of semenogelin in the diagnosis, prognosis and treatment of cancer' [patent_app_type] => new [patent_app_number] => 10/474213 [patent_app_country] => US [patent_app_date] => 2004-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8266 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214248.pdf [firstpage_image] =>[orig_patent_app_number] => 10474213 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/474213
Use of semenogelin in the diagnosis, prognosis and treatment of cancer Apr 2, 2002 Issued
Array ( [id] => 7408929 [patent_doc_number] => 20040019915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer' [patent_app_type] => new [patent_app_number] => 10/114432 [patent_app_country] => US [patent_app_date] => 2002-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 61 [patent_no_of_words] => 192045 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0019/20040019915.pdf [firstpage_image] =>[orig_patent_app_number] => 10114432 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/114432
Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer Mar 31, 2002 Abandoned
Array ( [id] => 800394 [patent_doc_number] => 07425538 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'HAUSP-p53 interaction and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/113732 [patent_app_country] => US [patent_app_date] => 2002-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 9 [patent_no_of_words] => 19619 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425538.pdf [firstpage_image] =>[orig_patent_app_number] => 10113732 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/113732
HAUSP-p53 interaction and uses thereof Mar 29, 2002 Issued
Array ( [id] => 6847063 [patent_doc_number] => 20030166230 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-04 [patent_title] => 'Methods and compositions for modulating tumor suppression' [patent_app_type] => new [patent_app_number] => 10/107521 [patent_app_country] => US [patent_app_date] => 2002-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 12735 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20030166230.pdf [firstpage_image] =>[orig_patent_app_number] => 10107521 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/107521
Methods and compositions for modulating tumor suppression Mar 24, 2002 Issued
Array ( [id] => 6651026 [patent_doc_number] => 20030105002 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'RGS compositions and therapeutic and diagnostic uses therefor' [patent_app_type] => new [patent_app_number] => 10/105004 [patent_app_country] => US [patent_app_date] => 2002-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 36863 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0105/20030105002.pdf [firstpage_image] =>[orig_patent_app_number] => 10105004 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/105004
RIEG compositions and therapeutic and diagnostic uses therefor Mar 21, 2002 Issued
Array ( [id] => 6830308 [patent_doc_number] => 20030181366 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Peptide inhibitors of Akt and uses thereof' [patent_app_type] => new [patent_app_number] => 10/103256 [patent_app_country] => US [patent_app_date] => 2002-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7161 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20030181366.pdf [firstpage_image] =>[orig_patent_app_number] => 10103256 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/103256
Peptide inhibitors of Akt and uses thereof Mar 20, 2002 Abandoned
Array ( [id] => 654454 [patent_doc_number] => 07108973 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => 'Human PEN11B-related gene variant associated with lung cancers' [patent_app_type] => utility [patent_app_number] => 10/102548 [patent_app_country] => US [patent_app_date] => 2002-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 3584 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/108/07108973.pdf [firstpage_image] =>[orig_patent_app_number] => 10102548 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/102548
Human PEN11B-related gene variant associated with lung cancers Mar 19, 2002 Issued
Array ( [id] => 6797459 [patent_doc_number] => 20030176333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'CASPR3: modulators of angiogenesis' [patent_app_type] => new [patent_app_number] => 10/100818 [patent_app_country] => US [patent_app_date] => 2002-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18399 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176333.pdf [firstpage_image] =>[orig_patent_app_number] => 10100818 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/100818
CASPR3: modulators of angiogenesis Mar 17, 2002 Abandoned
Array ( [id] => 623187 [patent_doc_number] => 07138122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Therapeutic systems' [patent_app_type] => utility [patent_app_number] => 10/099830 [patent_app_country] => US [patent_app_date] => 2002-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 21 [patent_no_of_words] => 20184 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138122.pdf [firstpage_image] =>[orig_patent_app_number] => 10099830 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/099830
Therapeutic systems Mar 12, 2002 Issued
Array ( [id] => 6774175 [patent_doc_number] => 20030017513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Insulin-like growth factor system and cancer' [patent_app_type] => new [patent_app_number] => 10/092769 [patent_app_country] => US [patent_app_date] => 2002-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 10480 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017513.pdf [firstpage_image] =>[orig_patent_app_number] => 10092769 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/092769
Insulin-like growth factor system and cancer Mar 6, 2002 Abandoned
Array ( [id] => 7180486 [patent_doc_number] => 20050124549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Method of modulating the proliferation of medullary thyroid carcinoma cells' [patent_app_type] => utility [patent_app_number] => 10/469835 [patent_app_country] => US [patent_app_date] => 2002-03-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8443 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124549.pdf [firstpage_image] =>[orig_patent_app_number] => 10469835 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/469835
Method of modulating the proliferation of medullary thyroid carcinoma cells Mar 5, 2002 Abandoned
Array ( [id] => 5845283 [patent_doc_number] => 20020132778 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-19 [patent_title] => 'Modulating angiogenesis' [patent_app_type] => new [patent_app_number] => 10/068591 [patent_app_country] => US [patent_app_date] => 2002-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6495 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20020132778.pdf [firstpage_image] =>[orig_patent_app_number] => 10068591 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/068591
Modulating angiogenesis Feb 5, 2002 Issued
Menu